Erratum: DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.

Erratum: DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncol Lett. 2020 Nov;20(5):218 Authors: Yong M, Yu T, Tian S, Liu S, Xu J, Hu J, Hu L Abstract [This corrects the article DOI: 10.3892/ol.2017.7184.]. PMID: 32963624 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research